ELIEM THERAPEUTICS INC (ELYM)

US28658R1068 - Common Stock

5.11  -0.05 (-0.97%)

After market: 5.1 -0.01 (-0.2%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
N/AN/A
EBITDA
YoY % growth
N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-7.45M-20.93M
-180.94%		-35.67M
-70.43%		-45.14M
-26.55%		-21.466M
52.45%		N/A
-65.15%		N/A
-49.29%
Operating Margin
N/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/AN/A-1.72
73.28%		N/A
22.91%		N/A
60.00%		N/A
-19.23%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2023
Q2Q % growth		 -0.25
50.00%		-0.260.011.96%
Q4 2022
Q2Q % growth		 -0.29
27.50%		-0.390.1025.18%
Q3 2022
Q2Q % growth		 -0.37
47.14%		-0.440.0716.13%
Q2 2022
Q2Q % growth		 -0.56
81.99%		-0.48-0.08-17.65%
Q1 2022
Q2Q % growth		 -0.50 -0.570.0712.98%
Q4 2021
Q2Q % growth		 -0.40 -0.630.2336.75%
Q3 2021
Q2Q % growth		 -0.70 -0.940.2425.67%
Q2 2021
Q2Q % growth		 -3.11 -1.90-1.21-63.49%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% 0%
RevenueN/A N/A N/A N/A